Short-term benefits of tolvaptan in hospital treatment of heart failure

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Cardiovascular Medicine | 2007年 / 4卷 / 8期
关键词：
D O I：
10.1038/ncpcardio0917
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：406 / 406
相关论文
共 50 条
  • [21] SHORT TERM USE OF TOLVAPTAN IN AN ADOLESCENT WITH CONGENITAL HEART DISEASE AND DECOMPENSATED FAILURE
    Busovsky-McNeal, Melissa
    Bhatla, Puneet
    Argilla, Michael
    Chakravarti, Sujata
    CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [22] Short-term adjusted outcomes for heart failure
    Messina, Gabriele
    Forni, Silvia
    Collini, Francesca
    Galdo, Antonello
    Di Fabrizio, Valeria
    Nante, Nicola
    HEART INTERNATIONAL, 2015, 10 (01): : E1 - E5
  • [23] Heart failure No early benefits of adjunct therapy with tolvaptan for acute heart failure
    Fernandez-Ruiz, Irene
    NATURE REVIEWS CARDIOLOGY, 2017, 14 (05) : 6 - 6
  • [24] Short-term impact of kampo goreisan in patients with congestive heart failure refractory to tolvaptan-incorporated medical therapy
    Hida, Yuki
    Imamura, Teruhiko
    Onoda, Hiroshi
    Kakeshita, Kota
    Kinugawa, Koichiro
    HEART AND VESSELS, 2024, 39 (12) : 1029 - 1035
  • [25] SHORT-TERM EFFECTS OF TOLVAPTAN ADDED TO FUROSEMIDE IN PATIENTS WITH CONGESTIVE HEART FAILURE AND ADVANCED STAGES OF CHRONIC KIDNEY DISEASE
    Tominaga, Naoto
    Shibagaki, Yugo
    Kida, Keisuke
    Miyake, Fumihiko
    Kimura, Kenjiro
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 137 - 137
  • [26] Clinical Characteristics, Treatment, and Short-Term Outcome in Patients with Heart Failure and Cancer
    Piotrowski, Jedrzej
    Timler, Malgorzata
    Kozlowski, Remigiusz
    Stasiak, Arkadiusz
    Stasiak, Joanna
    Bissinger, Andrzej
    Timler, Dariusz
    Timler, Wojciech
    Marczak, Michal
    Zaluska, Roman
    Piotrowski, Grzegorz
    CLINICS AND PRACTICE, 2021, 11 (04) : 933 - 941
  • [27] SHORT-TERM AND LONG-TERM DOBUTAMINE TREATMENT IN CHRONIC ISCHEMIC HEART-FAILURE
    LEWIN, RF
    DAVIDSON, E
    ZAFRIR, N
    STRASBERG, B
    SCLAROVSKY, S
    HELLMAN, C
    AGMON, J
    CLINICAL CARDIOLOGY, 1987, 10 (06) : 335 - 339
  • [28] No early benefits of adjunct therapy with tolvaptan for acute heart failure
    Irene Fernández-Ruiz
    Nature Reviews Cardiology, 2017, 14 : 256 - 256
  • [29] Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure - The EVEREST clinical status trials
    Gheorghiade, Mihai
    Konstam, Marvin A.
    Burnett, John C., Jr.
    Grinfeld, Liliana
    Maggioni, Aldo P.
    Swedberg, Karl
    Udelson, James E.
    Zannad, Faiez
    Cook, Thomas
    Ouyang, John
    Zimmer, Christopher
    Orlandi, Cesare
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (12): : 1332 - 1343
  • [30] TOLVAPTAN FOR THE TREATMENT OF HYPONATREMIA AND CONGESTIVE HEART FAILURE
    Ferrer, E.
    DRUGS OF TODAY, 2010, 46 (03) : 163 - 171
12345